Oct 2026· Journal of Vascular Diseases· Vol 5, pp. 42· 0 citations· 30 references
TL;DR
Liquid embolic agents achieved greater tumor devascularization and necrosis than particles, though surgical outcomes were comparable, though surgical outcomes (blood loss, operative time, complete resection rates) were comparable.
Abstract
Background/Objectives: Head and neck paragangliomas are rare, but hypervascular tumors for which preoperative embolization is often required to mitigate intraoperative blood loss. This study compares intraoperative and histopathological outcomes of paragangliomas following preoperative embolization using particles, EVOH, or nBCA. Methods: Retrospective analysis of patients undergoing preoperative embolization for paragangliomas at a tertiary care center from 2010 to 2025. Outcomes included post-embolization angiographic devascularization, intraoperative blood loss, histopathological tumor necrosis, inflammatory response, and surgical resection. Results: Twenty-four patients (17 female; median age 51.5 years) were included. The median interval between embolization and surgery was 1.5 days. Liquid embolic agents (EVOH: 54.2%, nBCA: 25.0%) were used in 79.2% of cases, with particles in the rest. Liquid embolics demonstrated superior angiographic tumor devascularization (median 90% vs. 50%, p = 0.036) and histopathological necrosis (30% vs. 0%, p = 0.019) compared to particles. However, no significant differences were observed in intraoperative blood loss (hemoglobin loss 1.4 g/dL for liquid embolics vs. 0.5 g/dL, p = 0.634), or intervention duration (137 min vs. 96 min, p = 0.053). Complete tumor resection (R0) was achieved in 74% of liquid embolic cases versus 100% with particles. EVOH and nBCA showed comparable embolization efficacy. Conclusions: Liquid embolic agents achieved greater tumor devascularization and necrosis than particles, though surgical outcomes (blood loss, operative time, complete resection rates) were comparable.
Embolization for head and neck paragangliomas was associated with early tumor volume reduction and short-term decreases in norepinephrine levels, suggesting that embolization may contribute to early anatomical and biochemical changes beyond its traditional role as a preoperative adjunct.
Hiroki Sakamoto, Takao Hashimoto, Ken Matsushima et al.· Neurologia medico-chirurgica· 0 citations
BACKGROUND AND OBJECTIVES
Single-session middle meningeal artery embolization (MMAE) combined with surgical evacuation is an emerging strategy for management of patients with chronic subdural hematoma (cSDH). However, comparative outcome data based on embolic material selection in this setting remain limited. We compar...
Immaculate Christie, D. Pichardo-Rojas, S. Gomez-Paz et al.· Operative Neurosurgery· 0 citations
Introduction Preoperative embolization is used selectively for central nervous system hemangioblastomas (CNS HBLs), but anatomical feasibility and procedural risk remain important uncertainties. Research question How feasible is embolization in selected CNS HBL cases? Material and methods We retrospectively reviewed a...
R. Doria-Medina, N. Neidert, M. Hohenhaus et al.· Brain and Spine· 1 citation
Introduction:
Carotid body tumors are rare, hypervascular paragangliomas at the carotid bifurcation. Preoperative embolization may facilitate resection, but intracranial migration of embolic material is an uncommon and severe complication.
Patient information:
A 44-year-old woman with a known left carotid body...
Santiago Pardo Jimenez, A. Guarnizo-Capera, J. A. Mejia· Circulation· 0 citations
If safe tumor growth control can be achieved, this study may provide preliminary evidence supporting standalone embolization as a potential less-invasive treatment strategy.
J. Haruma, Kenji Sugiu, Yusuke Tomita et al.· Neurologia medico-chirurgica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.